ELECOGLIPRON, AN ORAL SMALL MOLECULE GLP-1 RECEPTOR AGONIST IN ADULTS WITH OBESITY OR OVERWEIGHT (VISTA): A MULTICENTRE, PHASE 2, RANDOMISED, PLACEBO-CONTROLLED CLINICAL TRIAL

Descargar Publicación
Male Obesity and Cardiometabolic Risk: Inflammatory Mechanisms and Clinical Implications ACP publica guía sobre farmacoterapia para el sobrepeso y la obesidad